NovaBridge Biosciences (NBP) Long-Term Deferred Tax (2017 - 2022)
NovaBridge Biosciences (NBP) reported Long-Term Deferred Tax of $2.5 million for Q4 2022, down 53.41% on a QoQ basis from $5.4 million in Q4 2018.
NovaBridge Biosciences (NBP) has 3 years of Long-Term Deferred Tax data on file, last reported at $2.5 million in Q4 2022.
- Quarterly Long-Term Deferred Tax changed N/A year-over-year to $2.5 million in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $2.5 million (changed N/A YoY) and the FY2022 annual result came in at $2.6 million, changed N/A from the prior year.
- Long-Term Deferred Tax retreated to $2.5 million in Q4 2022 per NBP's latest filing, from $5.4 million in the prior quarter.
- Across five years, Long-Term Deferred Tax topped out at $5.4 million in Q4 2018 and bottomed at $2.5 million in Q4 2022.
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 2.51 Mn |
| Dec 31, 2018 | 5.38 Mn |
| Dec 31, 2017 | 5.62 Mn |